ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

SPRB Spruce Biosciences Inc

0,729
0,021 (2,97%)
Zuletzt aktualisiert: 20:04:09
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Spruce Biosciences Inc SPRB NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,021 2,97% 0,729 20:04:09
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,73 0,7101 0,7507 0,708
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
30.4.202422:05BWSpruce Biosciences Announces Additional Poster Presentation..
22.4.202422:05BWSpruce Biosciences Announces Upcoming Poster Presentation at..
13.3.202421:08BWSpruce Biosciences Reports Full Year 2023 Financial Results..
13.3.202421:01BWSpruce Biosciences Announces Topline Results from..
07.3.202422:07EDGAR2Form SC 13D/A - General statement of acquisition of..
06.2.202422:15EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
30.1.202422:05BWSpruce Biosciences to Present at the Oppenheimer 34th Annual..
22.1.202414:00BWSpruce Biosciences Completes Enrollment in CAHmelia-204..
08.1.202414:00EDGAR2Form 8-K - Current report
05.1.202414:00BWSpruce Biosciences Reports Baseline Characteristics from..
04.1.202414:00BWSpruce Biosciences Provides Clinical Program Updates and..
03.1.202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202302:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19.12.202302:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29.11.202301:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13.11.202322:22EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13.11.202322:09EDGAR2Form 8-K - Current report
13.11.202322:05BWSpruce Biosciences Reports Third Quarter 2023 Financial..
02.11.202321:05BWSpruce Biosciences to Participate in the Jefferies London..
18.10.202314:00BWSpruce Biosciences Completes Target Enrollment of..
28.8.202322:00BWSpruce Biosciences to Participate in the H.C. Wainwright..
14.8.202322:20EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202322:12EDGAR2Form 8-K - Current report
14.8.202322:00BWSpruce Biosciences Reports Second Quarter 2023 Financial..
06.7.202300:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06.7.202300:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.6.202322:00BWSpruce Biosciences Announces Acceptance of Abstract for..
25.5.202314:00BWSpruce Biosciences Appoints Percival Barretto-Ko to Board of..
24.5.202322:05BWSpruce Biosciences to Participate in the Jefferies..
22.5.202315:30BWSpruce Biosciences Honored at CARES Foundation 15th Annual..
15.5.202314:00BWSpruce Biosciences Reports First Quarter 2023 Financial..
04.5.202322:05BWSpruce Biosciences to Present Findings on Retrospective..
02.5.202322:05BWSpruce Biosciences to Participate in May Investor..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock